Dirk Kersten, Director at Dyne Therapeutics, Inc. (DYN), sold 1,377,576 shares at $17.72 ($26.3M) on 2026-03-09, disclosed to the SEC on 2026-03-11.
Open-market sale of $26.3M DYN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.72 | 177,690 | $3.1M | 12.0% |
| 2 | $17.72 | 177,690 | $3.1M | 12.0% |
| 3 | $18.21 | 9,482 | $173K | 0.7% |
| 4 | $18.21 | 9,482 | $173K | 0.7% |
| 5 | $19.32 | 219,758 | $4.2M | 16.1% |
| 6 | $19.33 | 219,758 |
| $4.2M |
| 16.2% |
| 7 | $19.80 | 281,858 | $5.6M | 21.2% |
| 8 | $19.80 | 281,858 | $5.6M | 21.2% |
| Total | $19.09 avg | 1,377,576 | $26.3M | 100% |
| Filing → |
| DYN | SELL | 2026-06-22 | $1.7M | — | Filing → |
| DYN | SELL | 2026-04-23 | $219K | — | Filing → |
| DYN | SELL | 2026-04-21 | $6.8M | — | Filing → |